RTW Biotech Opportunities Ltd
RTWFF
$1.30
-$0.03-2.26%
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 6.76M | 6.76M | 2.72M | 2.72M | 9.47M |
Total Receivables | 59.62M | 59.62M | 57.89M | 57.89M | 69.88M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 151.53M | 151.53M | 48.68M | 48.68M | 58.21M |
Total Current Assets | 217.91M | 217.91M | 109.29M | 109.29M | 137.56M |
|
|||||
Total Current Assets | 217.91M | 217.91M | 109.29M | 109.29M | 137.56M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.27M | 1.27M | 2.55M | 2.55M | 508.60K |
Total Assets | 777.21M | 777.21M | 446.23M | 446.23M | 416.54M |
|
|||||
Total Accounts Payable | 67.43M | 67.43M | 5.33M | 5.33M | 10.57M |
Total Accrued Expenses | 803.90K | 803.90K | 2.29M | 2.29M | 796.40K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 24.68M | 24.68M | 9.59M | 9.59M | 24.76M |
Total Other Current Liabilities | 24.68M | 24.68M | 9.59M | 9.59M | 24.76M |
Total Current Liabilities | 92.92M | 92.92M | 17.21M | 17.21M | 36.13M |
|
|||||
Total Current Liabilities | 92.92M | 92.92M | 17.21M | 17.21M | 36.13M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 92.92M | 92.92M | 17.21M | 17.21M | 36.13M |
|
|||||
Common Stock & APIC | 655.39M | 655.39M | 399.28M | 399.28M | 356.53M |
Retained Earnings | -- | -- | -- | -- | -- |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 655.39M | 655.39M | 399.28M | 399.28M | 356.53M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 655.39M | 655.39M | 399.28M | 399.28M | 356.53M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 28.90M | 28.90M | 29.74M | 29.74M | 23.88M |
Total Equity | 684.29M | 684.29M | 429.02M | 429.02M | 380.42M |
|